An interview with Glenn Saxe, computational psychiatrist, on the limitations of our current diagnostic system, and how causal ...

Success rates, particularly in phase 2 when efficacy is first tested, are below 30%. Causal AI for predicting clinical efficacy is currently transforming the pharma business model. The gold ...